Rheumatology
Conference Coverage
Researchers make headway in understanding axSpA diagnostic delay
A pilot study finds longer delays (more than 4 years) were associated with history of uveitis, ankylosing spondylitis at diagnosis, and being in...
Conference Coverage
Biomarkers for measuring lupus nephritis treatment response gain ground
A panel of protein biomarkers in urine could achieve better identification of lupus nephritis patients who are likely to respond to treatment.
Conference Coverage
MACE, VTE rates compared between TNF and JAK inhibitors for AxSpA and PsA
Patients with axial spondyloarthritis and psoriatic arthritis who used JAK inhibitors did not have higher risk of myocardial infarction or stroke...
From the Journals
Rheumatoid arthritis linked to increased Parkinson’s risk
“If patients with rheumatoid arthritis begin exhibiting motor symptoms such as muscle rigidity, tremors, or slowed movement, it is imperative that...
From the Journals
Cutaneous vasculitis curtails quality of life
Survey respondents described a generally poor health-related quality of life that was detailed as more severe with a skin-specific instrument than...
From the Journals
Colchicine’s 2010 price spike had major impact on gout care
Colchicine prescriptions dropped sharply and patient visits for gout-related symptoms increased significantly after a 2010 U.S. Food and Drug...
Conference Coverage
Care for patients with gout needs improvement, says doctor
Failure to understand the gout disease process and goals of urate-lowering therapy (ULT) is a key barrier to achieving optimal gout therapy.
Conference Coverage
Normal CRP during RA flares: An ‘underappreciated, persistent phenotype’
In about 5% of patients with seropositive RA, C-reactive protein levels were normal despite disease flares during a 5-year period. The findings...
Conference Coverage
Long-COVID rate may be higher with rheumatic diseases
The results highlight the need for close monitoring and optimized multidisciplinary care for long-term adverse events after COVID-19 in patients...
Conference Coverage
Can you spot hypermobility spectrum disorder?
“I think a lot of these patients were diagnosed with fibromyalgia,” Dr. Carroll said. “It’s incumbent upon us to be able to start teasing some of...
Conference Coverage
Meta-analysis examines cancer risk concern for JAK inhibitors
Although no increased cancer risk was seen vs. methotrexate or placebo, Janus kinase inhibitors were associated with a higher cancer risk than...